TrialCancer science2019

Sex differences in the safety of S-1 plus oxaliplatin and S-1 plus cisplatin for patients with metastatic gastric cancer.

Yasuhide Yamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.